|
|
NEW ON THE MARKET
|
|
Cannabinoid SATIVEX for spasticity due to multiple sclerosis
Apixaban (ELIQUIS) for prevention of thromboembolism
Me-too statin pitavastatin (LIVAZO)
|
|
|
THERAPY FROM A CRITICAL VIEWPOINT
|
|
No benefit: study with extended-release nicotinic acid (NIASPAN) stopped
|
|
|
a-t READER'S QUESTIONS AND COMMENTS
|
|
Concerning the off-label use of bevacizumab for macular degeneration
|
|
|
IN BRIEF
|
|
FOLFIRINOX for pancreatic cancer
Breast implants are not lifetime devices
Misleading sun protection factors
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Liver damage with UMCKALOABO
|
|
|
SIDE EFFECTS
|
|
Cave: myopathy due to simvastatin (ZOCOR, generics) 80 mg daily
End of glitazone antidiabetic pioglitazone (e.g. ACTOS)
Angiotensin II receptor antagonists: FDA finds no increased risk of cancer
|
|
|
e a-t IN THE INTERNET
|
|
What is the benefit of the meningococcal vaccine MENVEO?
|
|